1. India Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Eiko LifeSciences Ltd.

Eiko LifeSciences Ltd.

EIKO.BO
Eiko LifeSciences Ltd.IN flagBombay Stock Exchange
49.37
INR
-0.01
- -
708.25MMarket Cap
Eiko LifeSciences Ltd.
EIKO.BO
(Bombay Stock Exchange)

Recent

price

49.37

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
- -
- -
4.88
4.28
1.85
1.61
1.13
6.52
9.63
- -
27.2
28.22
18.72
27.07
28.98
- -
38.1
Revenue per Share
- -
-0.03
0.02
0.37
0.3
0.23
0.49
0.55
-1.01
0.29
1.39
0.78
0.79
0.73
1.62
- -
3.25
Basic EPS, GAAP
0.03
-0.02
5.43
-0.53
-0.8
0.54
-0.98
- -
0.37
1.75
-1.87
-8.57
4.32
-7.25
2.14
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.75
8.3
7.51
8.69
52.51
8.95
9.17
12.17
8.45
9.71
11.31
11.29
11.2
15.77
14.82
- -
10.37
Book Value per Share
0.75
8.3
7.51
8.69
52.51
8.95
9.17
15.35
10.26
11.8
28.42
31.76
30.06
49.13
43.86
- -
50.48
Tangible Book Value per Share
3
- -
- -
- -
1
3
3
4
4
4
4
9
10
10
13
- -
14
Basic Weighted Avg Shares
- -
- -
1
1
1
6
4
23
42
- -
120
254
183
279
377
527
527
Sales/Revenue/Turnover
- -
- -
0.34
12.38
24.42
16.89
59.49
11.48
-20.52
- -
3.85
3.19
1.79
3.41
5.37
12.18
12.18
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
1
2
1
1
6
6
3
7
10
10
Depreciation Expense
- -
- -
- -
- -
- -
1
2
2
-4
1
6
7
8
8
21
45
45
Net Income, GAAP
- -
- -
- -
30.32
32.18
28.98
24.07
18.4
- -
1.75
26.23
25.08
25.09
23.64
24.35
25.19
25.19
Effective Tax Rate (%)
- -
- -
0.36
8.56
16.13
14.28
42.98
8.4
-10.47
- -
5.12
2.77
4.2
2.69
5.59
8.53
8.53
Profit Margin (%)
2
2
- -
- -
1
5
7
13
1
- -
67
64
81
294
266
320
320
Working Capital
- -
- -
- -
- -
- -
- -
4
5
4
2
1
1
- -
- -
20
31
31
LT Debt
2
2
2
2
30
31
32
58
48
55
125
286
294
507
570
698
698
Total Equity
- -
- -
- -
4.17
1.09
2.09
5.11
3.93
- -
-3.8
3.39
2.55
0.78
1.81
2.76
7.12
7.12
Return on Invested Capital (%)
- -
- -
- -
4.14
1.06
2.49
5.19
5.26
- -
49.73
14.37
9.12
6.83
6.3
10.45
18.48
18.48
Return on Capital (%)
- -
-0.31
0.23
4.31
1.06
2.6
5.38
5.19
-11
3.19
13.26
9.31
7.27
5.52
11.85
26.75
26.75
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
17
LT Borrowings
10
- -
31
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
- -
14
Market Capitalization
711
749
688

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
284
- -
474
Cash, Cash Equivalents & STI
81
- -
136
Accounts Receivable, Net
145
- -
202
Inventories
21
- -
40
Total Current Liabilities
34
- -
154
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
17
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
44.77%
47.71%
22.49%
Free Cash Flow
- -
49.97%
-17.87%
Net Income, GAAP
36.9%
63.06%
113.53%
Sales/Revenue/Turnover
- -
42.28%
39.94%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
65
64
66
84
279
2025
108
82
75
113
377
2026
107
117
120
183
527

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
0.12
0.24
- -
0.73
2025
0.29
0.22
0.32
0.8
1.62
2026
0.66
0.78
0.88
0.93
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Sati Poly Plast Ltd. (SATIPOLY.NS)
Kansai Paint Co., Ltd. (4613.T)
Argus (Shanghai) Textile Chemicals Co.,Ltd. (603790.SS)
China General Plastics Corporation (1305.TW)
Eidai Kako Co.,Ltd. (7877.T)
Siam Pan Group Public Company Limited (SPG.BK)
Business
Eiko LifeSciences Ltd. (BSE: EIKO) manufactures, supplies and exports speciality chemicals and pharmaceutical intermediates primarily from its facility in Badlapur, Maharashtra, India. Incorporated in 1977 and headquartered in Thane, Maharashtra, the company offers active pharmaceutical ingredients (APIs), custom synthesis services, agrochemical intermediates, flavour and fragrance chemicals, cosmetic emollients, oleo chemicals and fine chemicals for applications in pharmaceuticals, agrochemicals, personal care, food, aroma chemicals, consumer goods and electronic chemicals; it serves domestic and international markets including Europe. In 2021, the company rebranded from Narendra Investments (Delhi) Limited to focus on chemicals, developed new molecules for agrochemicals, polymers and pharma in 2022, acquired a 25.01% stake in Reflux Pharmaceuticals Private Limited in 2023 to expand into APIs and European markets through co-marketing and raw material supply, and announced diversification into shipping, logistics and comprehensive supply chain services in November 2024.